GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Divi's Laboratories Ltd (BOM:532488) » Definitions » Sale Of Investment

Divi's Laboratories (BOM:532488) Sale Of Investment : ₹0 Mil (TTM As of Dec. 2024)


View and export this data going back to 2003. Start your Free Trial

What is Divi's Laboratories Sale Of Investment?

Divi's Laboratories's sale of investment for the three months ended in Dec. 2024 was ₹0 Mil. It means Divi's Laboratories gained ₹0 Mil from selling investments. Divi's Laboratories's sale of investment for the trailing twelve months (TTM) ended in Dec. 2024 was ₹0 Mil.

Compared with last quarter (₹0 Mil in Sep. 2024 ), Divi's Laboratories gained the same money from selling investments in Dec. 2024 (₹0 Mil).

Divi's Laboratories Sale Of Investment Historical Data

The historical data trend for Divi's Laboratories's Sale Of Investment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Divi's Laboratories Sale Of Investment Chart

Divi's Laboratories Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Sale Of Investment
Get a 7-Day Free Trial Premium Member Only Premium Member Only 15,895.70 11,421.00 505.00 16,010.00 39,490.00

Divi's Laboratories Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Sale Of Investment Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Divi's Laboratories Sale Of Investment Calculation

Sale of Investments represents cash inflow on the sale of investments in securities.

Sale Of Investment for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Divi's Laboratories Sale Of Investment Related Terms

Thank you for viewing the detailed overview of Divi's Laboratories's Sale Of Investment provided by GuruFocus.com. Please click on the following links to see related term pages.

Divi's Laboratories Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Divi's Laboratories Ltd (BOM:532488) » Definitions » Sale Of Investment
Comparable Companies
BOM:500087 NSE:TORNTPHARM BOM:543904 BOM:500124 BOM:500257 BOM:532321 NSE:AUROPHARMA BOM:500488 NSE:ALKEM BOM:532296 ZTS XTER:MRK NSE:SUNPHARMA TSE:4502 LSE:HLN XSWX:GALD HKSE:03692 XSWX:SDZ XTAE:TEVA SHSE:688506
Traded in Other Exchanges
DIVISLAB:India
Address
Cyber Hills, Divi Towers, 1-72/23(P)/DIVIS/303, Gachibowli, Hyderabad, TG, IND, 500032
Website
https://www.divislabs.com
Divi's Laboratories Ltd is a specialty and generic drug manufacturing company. It is engaged in the manufacture of Active Pharmaceutical ingredients (API), Intermediates, and Nutraceutical ingredients with a predominance in exports. It also through its custom synthesis, supports pharma companies for their patented products business from gram scale requirements for clinical trials to launch as well as late life cycle management. Geographically, the company derives a majority of its revenue through exports to countries like the United States of America, Switzerland, and other countries.

Divi's Laboratories Headlines

No Headlines